HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient

Artificial intelligence system shows performance at the level of

Antioxidants, Free Full-Text

Introducing heart rate variability monitoring combined with

先端AIのベンチャーが登場するSXSW2023のピッチファイナリスト

GPx (@GPx_Boston) / X

先端AIのベンチャーが登場するSXSW2023のピッチファイナリスト

Digital Health

Sean (Shunsuke) Matsuoka på LinkedIn: HRX 2022: GPX Inc: Novel AI

Pharmaceutics, Free Full-Text